β-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells

Experimental Hematology

Volumn 30, Issue 7, 2002, Pages 711-720

  Gupta, Deepak ^a   Podar, Klaus ^a   Tai, Yu Tzu ^a   Lin, Boris ^a   Hideshima, Teru ^a   Akiyama, Masaharu ^a   LeBlanc, Richard ^a   Catley, Laurence ^a   Mitsiades, Nicholas ^a   Mitsiades, Constantine ^a   Chauhan, Dharminder ^a   Munshi, Nikhil C ^a   Anderson, Kenneth C ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LAPACHONE; CASPASE 3; CASPASE 8; CASPASE 9; DEXAMETHASONE; DOXORUBICIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MELPHALAN; MITOXANTRONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; THYMIDINE; TRITIUM; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; MULTIPLE MYELOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BONE MARROW CELLS; CASPASES; CELL ADHESION; CELL DIVISION; DEXAMETHASONE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME PRECURSORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MELPHALAN; MITOXANTRONE; MULTIPLE MYELOMA; NAPHTHOQUINONES; NEOPLASM PROTEINS; PARACRINE COMMUNICATION; POLY(ADP-RIBOSE) POLYMERASES; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 18444383960     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00839-1     Document Type: Article

References (39)

1. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
2. β-lapachone: Synthesis of derivatives and activities in tumor models
3. Lomatiol. Part II. Its occurrence, constitution, relation to and conversion into lapachol. Also, a synthesis of lapachol
4. Comparison of antibacterial and antifungal activities of lapachol and β-lapachone
5. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi
6. Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi
7. β-lapachone, an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-α. Inhibitory effect, thiol dependence and specificity
8. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication
9. Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I
10. β-lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin
11. Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones
12. Potent inhibition of tumor survival in vivo by β-lapachone plus taxol: Combining drugs imposes different artificial checkpoints
13. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by β-lapachone in human carcinoma cells
14. β-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response
15. Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation-dependent pathway
16. Kip1) and Bak in the β-lapachone-induced apoptosis of human prostate cancer cells
17. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis
18. β-lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3
19. Nad(P)H:quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity
20. Calcium is a key signaling molecule in β-lapachone-mediated cell death
21. Isolation and characterization of human multiple myeloma cell enriched populations
22. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis and overcomes drug resistance in human multiple myeloma cells
23. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
24. WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-γ in multiple myeloma cells
25. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κB
26. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: Therapeutic applications
27. SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells
28. β-lapachone demonstrates activity against drug-resistant multiple myeloma cell lines and patient cells
29. β-lapachone shows significant activity against primary multiple myeloma (MM) cell lines, drug resistant MM cell lines and MM patient cells
30. β-lapachone, a novel topoisomerase I inhibitor, has significant cytotoxicity against multiple myeloma (MM) cell lines and patient cells
31. β-lapachone is safe and effective in biege-nude-xid mouse xenograft model of human plasmacytoma
32. Potent induction of apoptosis by β-lapachone in human multiple myeloma cell lines and patient cells
33. Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human multiple myeloma cell lines
34. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma
35. Biologic sequelae of NF-κB blockade in multiple myeloma: Therapeutic applications
36. Interleukin-6 triggers cell growth via the ras-dependent mitogen-activated protein kinase cascade
37. RAFTK/PYK2-dependent and independent apoptosis in multiple myeloma cells
38. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
39. Suppression of tumor necrosis factor-activated nuclear transcription factor-κB, activated protein-1, c-jun N-terminal kinase, and apoptosis by β-lapachone